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Autophosphorylation of the purified human insulin receptor tyrosyl kinase was found to be inhibited by 
the ras oncogene product p21 in a concentration- and GDP-dependent manner. GDP-j-I-S but not 
Gpp(NH)p could substitute for GDP in eliciting the ras-dependent inhibition. The inhibition was seen with 
both normal or mutant (Lysdl) ~21~~~ and normal or mutant (Val-12) ~21~““~. Inhibition occurred at 
23°C but not 4°C and was unaffected by the presence or absence of insulin although insulin stimulated the 
autophosphorylation rate of the receptor B-subunit some 2-fold. The insulin receptor did not phosphorylate 
native p2 1 Ha-ras in the presence or absence of added guanine nucleotide. After denaturation of p21Ha- with 
urea it became a substrate, but then failed to inhibit receptor autophosphorylation even in the presence 
of added GDP. 
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1. INTRODUCTION 
The receptors for insulin, EGF and PDGF as 
well as a variety of kinases expressed by oncogenes 
exhibit the ability to phosphorylate proteins on 
tyrosine residues [l-3]. However, there is, as yet, 
no clear indication of the physiological targets for 
these activities. Many cell surface receptors appear 
to generate intracellular signals by modulating the 
activity of an appropriate effector system via 
distinct guanine nucleotide regulatory proteins (G- 
proteins). Thus stimulation and inhibition of 
adenylate cyclase by a variety of hormone recep- 
tors are mediated via G, and Gi, respectively [5-81. 
Although no G-proteins have yet been identified 
that couple growth factor receptors to intracellular 
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effecters, there is some evidence that the ras gene 
product p21 may function in this way [9]. 
Recently it has been shown that the insulin 
receptor tyrosyl kinase can phosphorylate the 
holomeric, GDP-bound forms of the guanine 
nucleotide binding proteins Gi, G, and transducin 
[ 10,111. In addition, the tyrosyl kinase activity of 
the insulin receptor has been shown to be at- 
tenuated following phosphorylation by protein 
kinase C [ 121 and protein kinase A [ 131, while p21 
ras proteins have been shown to modify the 
phosphorylation of mitochondrial-associated pro- 
teins 1141. Moreover, protein kinase C has been 
shown to phosphorylate p21KimraS [15]. The 
physiological significance of these phosphoryla- 
tion events is not known. 
In the present study, we demonstrate a func- 
tional interaction between the insulin receptor and 
p21 ras proteins, where the GDP-bound form of 
p21 ras proteins attenuates the autophosphoryla- 
tion of the insulin receptor @subunit. 
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2. MATERIALS AND METHODS 
Protease inhibitors, Hepes, PMSF, DTT and all 
reagents for SDS-polyacrylamide gel electrophore- 
sis were purchased from Sigma, Poole, England. 
GDP, GDP-P-S, Gpp(NH)p and ATP were from 
Boehringer Mannheim, Lewes, England. Magne- 
sium chloride, manganese chloride and sodium 
metavanadate were from BDH Chemicals, Poole, 
England. Porcine monocomponent insulin was a 
generous gift from Novo Research Institute, 
Copenhagen, Denmark. [32P]Phosphate (PBS-l 1) 
was from Amersham, England and [Y-~~P]ATP 
was synthesized as described [ 161. 
Membranes from human placenta were prepared 
and then solubilised using Triton X-100 as de- 
scribed by Fujita-Yamaguchi et al. [17], except 
that 50 mM Hepes, pH 7.6, was used in place of 
the 50 mM Tris buffer. Furthermore, at the 
solubilisation step, the protease inhibitors pep- 
statin A, leupeptin and antipain were all added at 
1 pg/ml as well as benzamidine (2.5 mM) and 
PMSF (0.1 mM). The insulin receptor kinase was 
purified using an immunoadsorption technique 
employing a monoclonal anti-receptor antibody as 
described in detail elsewhere [18,191. 
Purification of p21NeTaS nd ~21~~-*~” hasbeen 
described [20]. The proteins were essentially 95% 
pure with only one band on Coomassie blue stain- 
ed gels. Where applicable p21Hamras was denatured 
by addition of 7 M urea, dialysed against 7 M urea 
to remove endogenous GDP for 24 h at 23°C and 
then renatured by dialysing against 10 mM Tris, 
pH 7.5 [21]. 
For the phosphorylation assay approx. 20 ng in- 
sulin receptor, immobilized on an immunoadsor- 
bent, was employed per assay (total volume 40 al). 
This is equivalent to a concentration of 2 nM in- 
sulin receptor. The final Triton X-100 concentra- 
tion in the assay was 0.1%. Unless stated 
otherwise, insulin (100 nM) was present. 
The experiments involved a series of different 
pre-incubations prior to the actual phosphoryla- 
tion assay. The receptor was pre-incubated in a 
total volume of 20~1 containing insulin receptor 
(4 nM) together with 24 mM MgC12, 4 mM 
MnC12, 0.2 mM NaV03 and 2 mM DTT in the 
presence or absence of 200 nM insulin. These were 
incubated for 15 min at 23°C prior to mixing with 
ras p21 together with guanine nucleotide 
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analogues, both at concentrations defined in the 
text. This mixture (total volume 30~1) was in- 
cubated for a further 10 min at 23°C. After 10 min 
this material (30 ~1) was mixed with IO/cl of 
0.4 mM [Y-~~P]ATP (2 /cCi/nmol) which was then 
incubated for 60 min at 23°C unless stated 
otherwise. 
Reactions were terminated by addition of 3 x 
concentrated electrophoresis ample buffer (20 ~1) 
containing 0.19 M Tris, pH 6.8, 6% (w/v) SDS, 
30% (v/v) glycerol, 15 mM EDTA, 300 mM DTT 
and 0.02% (w/v) bromophenol blue. After heating 
for 5 min at 100°C samples were analysed by elec- 
trophoresis on SDS-polyacrylamide gels (150 x 
150 x 1.5 mm) containing 15% (w/v) acrylamide 
[22]. Stained and dried gels were subjected to 
autoradiography. Results were quantified by exci- 
sion of the appropriate regions from the gel and 
determination of 32P by counting Cerenkov 
radiation. 
Analysis of the phosphoamino acid content of 
32P-labelled proteins eluted from SDS-polyacryl- 
amide gels was performed using chromatographic 
separation of phosphoamino acids as described 
~231. 
3. RESULTS 
Purification of p21 ras proteins from an E. coli 
expression system yielded a preparation containing 
one major band (21 kDa) on Coomassie staining 
[20]. The normal and mutant (Lysdl) forms of 
P21 N-ras and the normal and mutant (Val-12) forms 
of p21na-r=s were all assayed as possible substrates 
of the insulin receptor tyrosyl kinase, over a range 
of concentrations up to 40 pM. However, none of 
the ras p21 proteins were phosphorylated. Addi- 
tion of GDP (1 mM) or Gpp(NH)p (1 mM) did not 
cause ras p21 phosphorylation by the receptor 
kinase preparation. Under the conditions 
employed, histones and casein were both phos- 
phorylated efficiently by the insulin receptor. 
However, when normal p21HaeraS was first de- 
natured in 7 M urea and subsequently renatured by 
dialysis against 10 mM Tris, pH 7.5, it was found 
to provide a better substrate for the insulin recep- 
tor tyrosyl kinase. The K,,, for phosphorylation of 
denatured/renatured p21Hamras by the insulin recep- 
tor kinase was estimated to be 30pM and 4 x 
10e3 mol Pi were incorporated per mol p21Haeras 
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after 60 min at 23°C (fig.lA). The addition of 
either GDP (1 mM) or Gpp(NH)p (1 mM) had no 
effect on the kinetics of phosphorylation by the in- 
sulin receptor kinase. Furthermore, as expected 
phosphoamino acid analysis showed that both in- 
sulin receptor P-subunit and denatured/renatured 
P21 Ha-ras were phosphorylated on tyrosine residues 
(fig. 1B). 
Although native p21 Ha-ras was not a substrate for 
phosphorylation by the insulin receptor tyrosyl 
kinase it was found to inhibit insulin receptor 
autophosphorylation in the presence of GDP 
(fig.2). This effect was not seen with either GDP or 
P21 Ha-ras alone. Gpp(NH)p could not substitute 
for GDP in eliciting the inhibition (fig.3). p21Ha-‘a” 
yielded a dose-dependent inhibition with a half- 
maximal effect at approx. lo-20 PM at saturating 
A 
(i) (ii) 
Insulin 
- Receptor 
PSubunit 
GDP concentrations, and GDP gave a dose- 
dependent inhibition with a half-maximal effect at 
approx. 100 /IM in the presence of 20 yM p21Haeras 
(fig.4). 
The mutant (Val-12) form of p21HacraS and 
both the normal and mutant (Lys-61) forms of 
P21 N-ras also inhibited receptor autophosphoryla- 
tion in their GDP-bound forms and not 
Gpp(NH)p-bound forms, with similar GDP and 
p21 concentration dependencies. We found, 
however, that denatured/renatured normal 
P21 Ha-ras failed to inhibit receptor auto- 
phosphorylation in the presence of GDP (not 
shown), showing that such an action was exerted 
only by the native form of p21 ras. 
The inhibitory effect of p21 ras proteins on in- 
sulin receptor autophosphorylation was found to 
B 
-Serine (P) 
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-Origin 
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Fig. 1. Phosphorylation of denatured/renatured normal p21HaeraS by the insulin receptor tyrosyl kinase. (A) 
Autoradiograph of proteins separated on a 15% SDS-polyacrylamide gel. ~21~“.* (10 /tM) and insulin receptor (2 nM) 
were incubated for 60 min at 23°C with [Y-~~P]ATP (100,~M) in the phosphorylation assay; (i) denaturedkenatured 
P21 Ha-ras; (ii) native p21HammS. (B) Phosphoamino acid analysis of labelled proteins from the above experiment. 
255 
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be temperature dependent since the inhibition of 
autophosphorylation was not seen at 4°C yet was 
apparent at 23°C (fig.SA). The rate of insulin 
receptor autophosphorylation was reduced at 4°C 
Fig.2. Inhibition of insulin receptor autophosphoryla- 
tion by native ~21~~~‘~“. Autoradiograph shows insulin 
receptor P-subunit. Insulin receptor (2 nM) was 
,incubated with 20 ,uM p21 *‘-“’ for 60 min at 23°C with 
[y-32P]ATP (1OOpM) in the presence of either (i) no 
added guanine nucleotide, (ii) 1 mM GDP or (iii) 1 mM 
GPP(NWP. 
80 
f o 
Ha-m 
P21 (20 FM) Control (No ~21) 
Fig.3. Inhibition of insulin receptor autophosphoryla- 
tion by native p21Ha-“S. The histograms how data from 
three experiments. Autophosphorylation is expressed as 
a percentage of the phosphorylation in the absence of 
added guanine nucleotide. Insulin (2 nM) was incubated 
in the presence or absence of 20 pM p21HaeraS for 60 min 
at 23°C with [y-32P]ATP (100,zM) with either (i) no 
added guanine nucleotide, (ii) 1 mM GDP or (iii) 1 mM 
Fig.4. Dependence of p21HaeraS mediated inhibition of 
insulin receptor tyrosine kinase on GDP and p21Ha+aS 
concentration. Results show a typical experiment. (A) 
Insulin receptor (2 nM) was incubated in the presence of 
20 PM p2 1 Ha-ras for 60 min at 23°C with [y-32P]ATP 
(100 PM) with varying concentrations of GDP 
(O-2 mM). (B) Insulin receptor (2 nM) was incubated 
with 1 mM GDP and varying concentrations of p21HamraS 
(O-42pM) in the presence of [y-32P]ATP (1OOpM) for 
GPP(NH)P. 60 min at 23°C. 
compared to 23”C, but after incubating with 
[y-32P]ATP for 60 min at either 4°C or 23°C the 
insulin receptor P-subunit became maximally 
phosphorylated. Thus no effect of temperature 
was seen on the extent of autophosphorylation, in 
[ 
Ha-ras 
P21 ] -2oPM 
QDP (mf4 
1 4 11 21 42 ~21 (““1 
[GDP] - ImM 
4OQ-. 
. \. 
q 
E 
? 200 
5 
s 
3oo[ \ 
$ 
P ‘lm 
fj loo- 
I 
LT oL 
0 10 20 30 40 50 
[ 
Ha-m 
P21 ] (PM) 
256 
Volume 217, number 2 FEBS LETTERS June 1987 
0 0 
<- 23 C -a a- 4 c -, No Addltlon GDP GDP-O-S 
Fig.5. Effect of temperature (A) and GDP-P-S (B) on inhibition of insulin receptor autophosphorylation by normal 
P21 Ha-ras. Autophosphorylation is expressed as a percentage of the phosphorylation in the absence of added guanine 
nucleotide. (A) Insulin receptor (2 nM) was incubated with 20pM p21 Ha-ras for 60 min at either 23°C or 4°C with 
[Y-~~P]ATP (1OOpM) with either (i) no added guanine nucleotide, (ii) 1 mM GDP or (iii) 1 mM Gpp(NH)p. (B) Insulin 
receptor (2 nM) was incubated with 20pM p21Ha-“” for 60 min at 23°C with [y-32P]ATP (100pM) with either (i) no 
added guanine nucleotide, (ii) 1 mM GDP or (iii) 1 mM GDP-&S. 
the absence of p21 ras, in this experiment. We also evidence suggests that they are subject to control 
found that replacement of GDP by GDP-&S by phosphorylation/dephosphorylation reactions. 
maintained the ability of the various p21 ras pro- Thus protein kinase C can phosphorylate and inac- 
teins to inhibit receptor autophosphorylation tivate Gi [25] and the insulin receptor tyrosyl 
(fig.SB). This shows that the reaction is specific for kinase has been shown to be capable of 
GDP and obviates any possible conversion of phosphorylating the holomeric, GDP-bound 
bound GDP to GTP on ras ~21. forms of Gi, G, [lo] and transducin [l 11. 
The presence or absence of insulin in the recep- 
tor kinase assay appeared to have little effect on 
p21 ras-mediated inhibition of receptor autophos- 
phorylation. Thus in the presence of GDP (1 mM) 
and p21Hamras (20 PM), inhibition of phosphoryla- 
tion during a 5 min assay period at 23°C was 60 
and 40% in the absence and presence of insulin, 
respectively. 
4. DISCUSSION 
Guanine nucleotide-binding proteins (G-pro- 
teins) provide a means whereby receptors can cou- 
ple to and regulate distinct effector systems. It 
would appear, however, that their functioning can 
be attenuated during certain desensitization pro- 
cesses (see for example [24]) or following their 
ribosylation by various toxins [5-S]. Recent 
Here we show that native p21 ras proteins, 
which are G-proteins, are not substrates for the in- 
sulin receptor tyrosyl kinase. However, after a cy- 
cle of denaturation and renaturation then p21Haeras 
provides a better substrate for this tyrosyl kinase 
activity. (The Km for phosphorylation of ~21~~-‘~” 
by the insulin receptor kinase was estimated to be 
30pM in the presence of insulin. This compares 
with values of around lo-100pM for histones, 
lo-20 /cM for casein, 5-10 PM for poly Glu 4: Tyr 
1, and 2-4 mM for angiotensin and the src-related 
peptide [26,27].) This suggests that the urea 
denaturation/renaturation cycle used by a number 
of workers in the purification of ras p21 [21] may 
profoundly disturb the structure of this molecule. 
As such our observations question the advisability 
of using such a protocol to prepare p21 ras pro- 
teins for either structural or functional analysis. 
257 
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Although we found that native ras p21 did not 
provide a substrate for the insulin receptor tyrosyl 
kinase we did observe that the native, but not 
denatured forms of the normal and mutant 
(Lys-61) p21 N-ras pecies as well as the normal and 
mutant (Val-12) species of p21Hahras could all in- 
hibit the ability of the insulin receptor to undergo 
autophosphorylation. Such an inhibitory effect 
was dose dependent upon p21 ras and interesting- 
ly, dependent upon GDP being present. It did not 
occur when the non-hydrolysable GTP analogue, 
Gpp(NH)p, was present but was evident when the 
non-phosphorylatable analogue of GDP, GDP-,&S 
was employed. Inhibition by p21 ras was exerted 
on the basal kinase activity as well as that 
stimulated by insulin and whilst observed at 23°C 
was not evident at 4°C. 
The mechanism of ras/GDP-mediated inhibi- 
tion of receptor autophosphorylation is unclear. 
The effect cannot be explained by depletion of 
ATP in the assay mixture (not shown). p21Haeras is 
not itself phosphorylated under the conditions in 
which receptor phosphorylation is inhibited, so it 
does not act as a competitive substrate for the 
tyrosyl kinase. It is interesting that the extent of in- 
hibition is very similar whether the initial rate of 
phosphorylation is measured after 5 min or the 
plateau of incorporation after 60 min. This sug- 
gests that ras might be acting to block 
phosphorylation sites on the receptor rather than 
to inhibit the kinase activity per se. Experiments 
with exogenous ubstrates will help to resolve this 
issue. 
Normal cellular p21 ras proteins are found in 
most if not all cell types, with oncogenic forms be- 
ing identified as having single point mutations. 
Evidence has been provided which indicates that 
such proteins may act as regulatory G-proteins 
able to couple growth factor receptors to 
phospholipase C in order to stimulate inositol 
phospholipid metabolism in certain cells where 
such responses are unaffected by pertussis toxin 
[9]. Our observations here indicate that the 
unstimulated, GDP-bound form of p21 ras can in- 
hibit insulin receptor autophosphorylation. As 
autophosphorylation can lead to increased kinase 
activity ]28,29] and is believed to be crucial to 
receptor functioning [4,30], it is possible that p21 
ras might exert a tonic inhibitory effect on insulin 
receptor functioning. One might expect this to be 
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relieved only when an appropriate occupied recep- 
tor was able to interact with p21 ras, converting it 
to an active GTP-bound form, hence relieving the 
tonic inhibition. This might offer an explanation 
for the synergising action of insulin and various 
growth factors in stimulating growth [31,32]. It 
will thus be of interest to attempt to demonstrate 
whether such interactions can occur in intact cells 
where diffusion of such components is confined to 
the 2-dimensions of the bilayer, such that the con- 
centration of p21 ras required for half-maximal in- 
hibition and its GDP sensitivity may be 
significantly reduced, and to define the conse- 
quences of such an interacting system. 
Interestingly, recent work using Xenopus 
oocytes has demonstrated a possible, if indirect, 
interaction between the insulin receptor and p21 
ras proteins since insulin induction of oocyte 
maturation is inhibited by a monoclonal antibody 
to p21 [33]. 
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